Postmenopausal Vaginal Atrophy Treatment Global Market Report 2025

Published Jul 07, 2025

Length 175 Pages

SKU # BRC20166175

Description

Postmenopausal Vaginal Atrophy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postmenopausal vaginal atrophy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for postmenopausal vaginal atrophy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postmenopausal vaginal atrophy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Estrogen Based Drugs; Non-Estrogen Based Drugs; Other Therapy Types

2) By Route Of Administration: Oral; Intravaginal; Other Routes Of Administration

3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

4) By Application: Gynecology; Sexual Health; Pharmaceuticals

5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Estrogen Based Drugs: Oral Estrogen Therapy; Transdermal Estrogen Therapy; Estrogen Implants; Vaginal Estrogen Therapy; Branded Products

2) By Non-Estrogen Based Drugs: Selective Estrogen Receptor Modulators; Prasterone; Other Non-Estrogen Hormonal Agents

3) By Other Therapy Types: Non-Drug Therapies; Over-The-Counter Products

Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Novo Nordisk A/S

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Postmenopausal Vaginal Atrophy Treatment Market Characteristics
3. Postmenopausal Vaginal Atrophy Treatment Market Trends And Strategies
4. Postmenopausal Vaginal Atrophy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Postmenopausal Vaginal Atrophy Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Postmenopausal Vaginal Atrophy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Postmenopausal Vaginal Atrophy Treatment Market Growth Rate Analysis; 5.4. Global Postmenopausal Vaginal Atrophy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Postmenopausal Vaginal Atrophy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Postmenopausal Vaginal Atrophy Treatment Total Addressable Market (TAM)
6. Postmenopausal Vaginal Atrophy Treatment Market Segmentation: 6.1. Global Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Estrogen Based Drugs; Non-Estrogen Based Drugs; Other Therapy Types; 6.2. Global Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Intravaginal; Other Routes Of Administration; 6.3. Global Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacy; Online Pharmacy; Retail Pharmacy; 6.4. Global Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Gynecology; Sexual Health; Pharmaceuticals; 6.5. Global Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Homecare; Specialty Clinics; Other End-Users; 6.6. Global Postmenopausal Vaginal Atrophy Treatment Market, Sub-Segmentation Of Estrogen Based Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral Estrogen Therapy; Transdermal Estrogen Therapy; Estrogen Implants; Vaginal Estrogen Therapy; Branded Products; 6.7. Global Postmenopausal Vaginal Atrophy Treatment Market, Sub-Segmentation Of Non-Estrogen Based Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Selective Estrogen Receptor Modulators; Prasterone; Other Non-Estrogen Hormonal Agents; 6.8. Global Postmenopausal Vaginal Atrophy Treatment Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Non-Drug Therapies; Over-The-Counter Products
7. Postmenopausal Vaginal Atrophy Treatment Market Regional And Country Analysis: 7.1. Global Postmenopausal Vaginal Atrophy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Postmenopausal Vaginal Atrophy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market: 8.1. Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Postmenopausal Vaginal Atrophy Treatment Market: 9.1. China Postmenopausal Vaginal Atrophy Treatment Market Overview; 9.2. China Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Postmenopausal Vaginal Atrophy Treatment Market: 10.1. India Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Postmenopausal Vaginal Atrophy Treatment Market: 11.1. Japan Postmenopausal Vaginal Atrophy Treatment Market Overview; 11.2. Japan Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Postmenopausal Vaginal Atrophy Treatment Market: 12.1. Australia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Postmenopausal Vaginal Atrophy Treatment Market: 13.1. Indonesia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Postmenopausal Vaginal Atrophy Treatment Market: 14.1. South Korea Postmenopausal Vaginal Atrophy Treatment Market Overview; 14.2. South Korea Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Postmenopausal Vaginal Atrophy Treatment Market: 15.1. Western Europe Postmenopausal Vaginal Atrophy Treatment Market Overview; 15.2. Western Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Postmenopausal Vaginal Atrophy Treatment Market: 16.1. UK Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Postmenopausal Vaginal Atrophy Treatment Market: 17.1. Germany Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Postmenopausal Vaginal Atrophy Treatment Market: 18.1. France Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Postmenopausal Vaginal Atrophy Treatment Market: 19.1. Italy Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Postmenopausal Vaginal Atrophy Treatment Market: 20.1. Spain Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Postmenopausal Vaginal Atrophy Treatment Market: 21.1. Eastern Europe Postmenopausal Vaginal Atrophy Treatment Market Overview; 21.2. Eastern Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Postmenopausal Vaginal Atrophy Treatment Market: 22.1. Russia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Postmenopausal Vaginal Atrophy Treatment Market: 23.1. North America Postmenopausal Vaginal Atrophy Treatment Market Overview; 23.2. North America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Postmenopausal Vaginal Atrophy Treatment Market: 24.1. USA Postmenopausal Vaginal Atrophy Treatment Market Overview; 24.2. USA Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Postmenopausal Vaginal Atrophy Treatment Market: 25.1. Canada Postmenopausal Vaginal Atrophy Treatment Market Overview; 25.2. Canada Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Postmenopausal Vaginal Atrophy Treatment Market: 26.1. South America Postmenopausal Vaginal Atrophy Treatment Market Overview; 26.2. South America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Postmenopausal Vaginal Atrophy Treatment Market: 27.1. Brazil Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Postmenopausal Vaginal Atrophy Treatment Market: 28.1. Middle East Postmenopausal Vaginal Atrophy Treatment Market Overview; 28.2. Middle East Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Postmenopausal Vaginal Atrophy Treatment Market: 29.1. Africa Postmenopausal Vaginal Atrophy Treatment Market Overview; 29.2. Africa Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Postmenopausal Vaginal Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Postmenopausal Vaginal Atrophy Treatment Market Competitive Landscape And Company Profiles: 30.1. Postmenopausal Vaginal Atrophy Treatment Market Competitive Landscape; 30.2. Postmenopausal Vaginal Atrophy Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
31. Postmenopausal Vaginal Atrophy Treatment Market Other Major And Innovative Companies: 31.1. Viatris Inc.; 31.2. Teva Pharmaceutical Industries Ltd.; 31.3. Perrigo Company; 31.4. Shionogi & Co. Ltd.; 31.5. Hikma Pharmaceuticals; 31.6. Amneal Pharmaceuticals LLC; 31.7. Lupin Pharmaceuticals; 31.8. Mayne Pharma; 31.9. Upsher-Smith Laboratories; 31.10. Alvogen; 31.11. Ligand Pharmaceuticals Incorporated; 31.12. Dare Bioscience; 31.13. Millicent Pharma Limited; 31.14. TherapeuticsMD; 31.15. Bionovo Inc.
32. Global Postmenopausal Vaginal Atrophy Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Postmenopausal Vaginal Atrophy Treatment Market
34. Recent Developments In The Postmenopausal Vaginal Atrophy Treatment Market
35. Postmenopausal Vaginal Atrophy Treatment Market High Potential Countries, Segments and Strategies: 35.1 Postmenopausal Vaginal Atrophy Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Postmenopausal Vaginal Atrophy Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Postmenopausal Vaginal Atrophy Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now